当前位置: X-MOL 学术Mol. Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
Molecular Cell ( IF 14.5 ) Pub Date : 2019-11-13 , DOI: 10.1016/j.molcel.2019.10.014
Yurena Vivas-García 1 , Paola Falletta 1 , Jana Liebing 2 , Pakavarin Louphrasitthiphol 1 , Yongmei Feng 3 , Jagat Chauhan 1 , David A Scott 3 , Nicole Glodde 2 , Ana Chocarro-Calvo 4 , Sarah Bonham 5 , Andrei L Osterman 3 , Roman Fischer 5 , Ze'ev Ronai 3 , Custodia García-Jiménez 6 , Michael Hölzel 2 , Colin R Goding 1
Affiliation  

Phenotypic and metabolic heterogeneity within tumors is a major barrier to effective cancer therapy. How metabolism is implicated in specific phenotypes and whether lineage-restricted mechanisms control key metabolic vulnerabilities remain poorly understood. In melanoma, downregulation of the lineage addiction oncogene microphthalmia-associated transcription factor (MITF) is a hallmark of the proliferative-to-invasive phenotype switch, although how MITF promotes proliferation and suppresses invasion is poorly defined. Here, we show that MITF is a lineage-restricted activator of the key lipogenic enzyme stearoyl-CoA desaturase (SCD) and that SCD is required for MITFHigh melanoma cell proliferation. By contrast MITFLow cells are insensitive to SCD inhibition. Significantly, the MITF-SCD axis suppresses metastasis, inflammatory signaling, and an ATF4-mediated feedback loop that maintains de-differentiation. Our results reveal that MITF is a lineage-specific regulator of metabolic reprogramming, whereby fatty acid composition is a driver of melanoma phenotype switching, and highlight that cell phenotype dictates the response to drugs targeting lipid metabolism.

中文翻译:

MITF对SCD和脂肪酸饱和度的谱系限制调节可控制黑色素瘤表型可塑性。

肿瘤内的表型和代谢异质性是有效癌症治疗的主要障碍。如何代谢涉及特定的表型,以及谱系限制机制是否控制关键的代谢脆弱性仍然知之甚少。在黑色素瘤中,尽管MITF如何促进增殖和抑制侵袭,但对成瘾成因癌基因小眼症相关转录因子(MITF)的下调是增生-侵袭表型转换的标志。在这里,我们显示MITF是关键脂肪生成酶硬脂酰辅酶A去饱和酶(SCD)的谱系限制激活剂,并且SCD是MITFHigh黑色素瘤细胞增殖所必需的。相比之下,MITFLow细胞对SCD抑制不敏感。值得注意的是,MITF-SCD轴可抑制转移,炎症信号传导,以及由ATF4介导的反馈回路,可保持去分化。我们的结果表明,MITF是代谢重编程的谱系特异性调节剂,其中脂肪酸组成是黑色素瘤表型转换的驱动力,并强调了细胞表型决定了对靶向脂质代谢的药物的反应。
更新日期:2019-11-13
down
wechat
bug